Literature DB >> 16259945

A role for 3-O-sulfotransferase isoform-4 in assisting HSV-1 entry and spread.

Vaibhav Tiwari1, Christopher D O'Donnell, Myung-Jin Oh, Tibor Valyi-Nagy, Deepak Shukla.   

Abstract

Many heparan sulfate (HS) 3-O-sulfotransferase (3-OST) isoforms generate cellular receptors for herpes simplex virus type-1 (HSV-1) glycoprotein D (gD). Interestingly, the ability of 3-OST-4 to mediate HSV-1 entry and cell-to-cell fusion has not been determined, although it is predominantly expressed in the brain, a primary target of HSV-1 infections. We report that expression of 3-OST-4 can render Chinese hamster ovary K1 (CHO-K1) cells susceptible to entry of wild-type and a mutant (Rid1) strain of HSV-1. Evidence for generation of gD receptors by 3-OST-4 was suggested by gD-mediated interference assay and the ability of 3-OST-4 expressing CHO-K1 cells to preferentially bind HSV-1 gD, which could be reversed by prior treatment of cells with HS lyases (heparinases-II/III). In addition, 3-OST-4 expressing CHO-K1 cells acquired the ability to fuse with cells-expressing HSV-1 glycoproteins. Demonstrating specificity, the cell fusion was inhibited by soluble 3-O-sulfated forms of HS, but not unmodified HS. Taken together our results suggest a role of 3-OST-4 in HSV-1 pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259945     DOI: 10.1016/j.bbrc.2005.10.056

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  Role of heparan sulfate in sexually transmitted infections.

Authors:  Vaibhav Tiwari; Erika Maus; Ira M Sigar; Kyle H Ramsey; Deepak Shukla
Journal:  Glycobiology       Date:  2012-07-06       Impact factor: 4.313

2.  Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts.

Authors:  Vaibhav Tiwari; Christian Clement; Ding Xu; Tibor Valyi-Nagy; Beatrice Y J T Yue; Jian Liu; Deepak Shukla
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 3.  Role of heparan sulfate in ocular diseases.

Authors:  Paul J Park; Deepak Shukla
Journal:  Exp Eye Res       Date:  2013-02-11       Impact factor: 3.467

4.  Role of 3-O-sulfated heparan sulfate in virus-induced polykaryocyte formation.

Authors:  Vaibhav Tiwari; Gerdy B ten Dam; Beatrice Y J T Yue; Toin H van Kuppevelt; Deepak Shukla
Journal:  FEBS Lett       Date:  2007-08-24       Impact factor: 4.124

5.  Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1.

Authors:  Ronald Copeland; Arun Balasubramaniam; Vaibhav Tiwari; Fuming Zhang; Arlene Bridges; Robert J Linhardt; Deepak Shukla; Jian Liu
Journal:  Biochemistry       Date:  2008-05-06       Impact factor: 3.162

6.  A role for heparan sulfate in viral surfing.

Authors:  Myung-Jin Oh; Jihan Akhtar; Prashant Desai; Deepak Shukla
Journal:  Biochem Biophys Res Commun       Date:  2009-11-10       Impact factor: 3.575

7.  The Importance of Heparan Sulfate in Herpesvirus Infection.

Authors:  Christopher D O'Donnell; Deepak Shukla
Journal:  Virol Sin       Date:  2008-12-01       Impact factor: 4.327

Review 8.  Understanding the substrate specificity of the heparan sulfate sulfotransferases by an integrated biosynthetic and crystallographic approach.

Authors:  Jian Liu; Andrea F Moon; Juzheng Sheng; Lars C Pedersen
Journal:  Curr Opin Struct Biol       Date:  2012-07-26       Impact factor: 6.809

9.  Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X.

Authors:  Angela C Bradshaw; Alan L Parker; Margaret R Duffy; Lynda Coughlan; Nico van Rooijen; Veli-Matti Kähäri; Stuart A Nicklin; Andrew H Baker
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

10.  The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues.

Authors:  Roger Lawrence; Tomio Yabe; Sassan Hajmohammadi; John Rhodes; Melissa McNeely; Jian Liu; Edward D Lamperti; Paul A Toselli; Miroslaw Lech; Patricia G Spear; Robert D Rosenberg; Nicholas W Shworak
Journal:  Matrix Biol       Date:  2007-03-30       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.